Why the study?
Hypertension drives cardiac remodeling and renal damage, linked to renal sympathetic hyperactivation, but the effects of renal nerve denervation on blood pressure and target organ changes across different hypertensive models needed evaluation.
Does renal nerve denervation reduce blood pressure and target organ damage in hypertensive rat models?
Does renal nerve denervation reduce blood pressure and target organ damage in hypertensive rat models?
Renal denervation performed prior to the onset of hypertension significantly lowers blood pressure in a secondary hypertension rat model.
Does not support clinical RDN use; leaves open preventive timing in secondary hypertension models.
BACKGROUND: Hypertension contributes to the progression of cardiac remodeling and renal damage. In turn, renal sympathetic hyperactivation showed elevated sympathetic nervous system activity and led to blood pressure increase in certain patients. The purpose of this study was to observe the effect of renal nerve denervation on blood pressure and target organ changes in two hypertensive rat models. METHODS: Hypertensive rats were randomly divided into a renal denervation (RDN) group and sham operation group. Wistar-Kyoto (WKY) rats of the same age were set as the baseline control group. In the secondary hypertension model, SD rats were randomly divided into five groups. Blood pressure and bodyweight were measured every week until they were euthanized. RESULTS: The two rat models underwent RDN at key timepoints. At these timepoints, the hearts and kidneys were collected for norepinephrine and angiotensin II measurements and histological analysis. CONCLUSION: RDN performed before development of hypertension showed a significant antihypertensive effect on the secondary hypertension model.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: